Amphastar Pharmaceuticals Cash on Hand 2012-2024 | AMPH

Amphastar Pharmaceuticals cash on hand from 2012 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Amphastar Pharmaceuticals Annual Cash on Hand
(Millions of US $)
2023 $259
2022 $178
2021 $139
2020 $110
2019 $90
2018 $93
2017 $72
2016 $74
2015 $67
2014 $69
2013 $55
2012 $52
2011 $
2009 $18
Amphastar Pharmaceuticals Quarterly Cash on Hand
(Millions of US $)
2024-06-30 $220
2024-03-31 $292
2023-12-31 $259
2023-09-30 $306
2023-06-30 $168
2023-03-31 $195
2022-12-31 $178
2022-09-30 $187
2022-06-30 $186
2022-03-31 $189
2021-12-31 $139
2021-09-30 $117
2021-06-30 $139
2021-03-31 $118
2020-12-31 $110
2020-09-30 $103
2020-06-30 $103
2020-03-31 $71
2019-12-31 $90
2019-09-30 $102
2019-06-30 $127
2019-03-31 $86
2018-12-31 $93
2018-09-30 $76
2018-06-30 $55
2018-03-31 $62
2017-12-31 $72
2017-09-30 $74
2017-06-30 $87
2017-03-31 $79
2016-12-31 $74
2016-09-30 $69
2016-06-30 $68
2016-03-31 $65
2015-12-31 $67
2015-09-30 $72
2015-06-30 $76
2015-03-31 $70
2014-12-31 $69
2014-09-30 $74
2014-06-30 $66
2014-03-31 $53
2013-12-31 $55
2013-09-30
2013-06-30
2013-03-31
2012-12-31 $52
2012-09-30
2012-06-30
2012-03-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.469B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.597B 2.61
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00